HealthEquity director reports 2,033-share position

The restricted stock units vest in full on the date of HealthEquity’s annual stockholder meeting in June 2027.

Rhea-AI Filing Summary

HealthEquity, Inc. director Noemie Clemence Heuland reported a direct common-stock position of 2,033 shares. The linked footnote describes restricted stock units, each a contingent right to one share, that vest in full on the date of the issuer’s annual stockholder meeting in June 2027; vested shares will be delivered upon vesting.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Heuland Noemie Clemence

Role Director

Type	Security	Shares	Price	Value
holding	Common Stock F1	--	--	--

Holdings After Transaction: Common Stock — 2,033 shares (Direct)

Footnotes (1)

1. F1. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the date of the issuer's annual stockholder meeting in June of 2027. Vested shares will be delivered to the reporting person upon vesting.

Key Figures

Direct common-stock position: 2,033 shares Shares per restricted stock unit: 1 share Restricted stock unit vesting: June 2027

3 metrics

Direct common-stock position 2,033 shares Reported by director Noemie Clemence Heuland

Shares per restricted stock unit 1 share Each restricted stock unit represents a contingent right to one share

Restricted stock unit vesting June 2027 On the date of the issuer’s annual stockholder meeting

Key Terms

restricted stock units, contingent right, Section 16 Reporting Obligations

3 terms

restricted stock units financial

"The restricted stock units vest in full"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"represents a contingent right to receive one share"

Section 16 Reporting Obligations regulatory

"Power of Attorney for Section 16 Reporting Obligations"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did HealthEquity director Noemie Clemence Heuland report?

Noemie Clemence Heuland reported a direct position of 2,033 shares under the common-stock entry. The associated footnote describes restricted stock units, each representing a contingent right to receive one share.

When do Noemie Clemence Heuland’s HealthEquity restricted stock units vest?

The restricted stock units vest in full on the date of HealthEquity’s annual stockholder meeting in June 2027. Vested shares will be delivered to Noemie Clemence Heuland upon vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/30/2026 - 04:42 PM Accepted by SEC EDGAR 09/30/2026 - 04:42 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Heuland Noemie Clemence

(Last) (First) (Middle)

C/O HEALTHEQUITY, INC.

15 W. SCENIC POINTE DR., STE. 100

(Street)

DRAPER UTAH 84020

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/24/2026

3. Issuer Name and Ticker or Trading Symbol
HEALTHEQUITY, INC. [ HQY ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2,033(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the date of the issuer's annual stockholder meeting in June of 2027. Vested shares will be delivered to the reporting person upon vesting.

Remarks:

The Limited Power of Attorney for Section 16 Reporting Obligations executed by Ms. Heuland on September 29, 2026 is attached as an exhibit to this statement on Form 3 filed by Ms. Heuland with respect to HealthEquity, Inc. and is hereby incorporated by reference.

	/s/ Michael Newton, Attorney-in-Fact	09/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)